Metabolomic analysis of blood spots in a Chinese cohort with autism spectrum disorders: a pilot study
- PMID: 40540229
- DOI: 10.1007/s11011-025-01635-5
Metabolomic analysis of blood spots in a Chinese cohort with autism spectrum disorders: a pilot study
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a strong genetic component that is becoming increasingly prevalent. The identification of plasma molecular biomarkers may provide potential insights into ASD and aid in early diagnosis. In this study, we characterized the metabolomic profiles of ASD children using blood spot samples collected at the Children's Hospital of Zhejiang University School of Medicine from children with ASD (n = 43) and typically developing (TD) children (n = 43). Our results highlight differences between children with ASD and TD controls. We identified possibly associations between ASD and a variety of metabolites, including carnosine (Car), glutaric acid, histidine (His), succinic acid, tryptophan, glutamine (Gln), asparagine, guanidinoacetic acid, sarcosine, kynurenine, glutamic acid (Glu) and cysteine (Cys). Metabolic pathway analysis demonstrated a possible imbalance in the amino acid metabolism of Glu/Gln, Car/His in ASD children. These findings may provide new insights into the molecular mechanisms that influence ASD risk and have possibility for the discovery of biomarkers.
Keywords: Analysis; Autism spectrum disorder; Biomarker; Chinese; Metabolomic.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of the Children’s Hospital of Zhejiang University School of Medicine (2023-IRB-0307-P-01). The parents or guardians of all the included children signed the informed consent forms. Consent for publication: All authors agree to publish the manuscript. Competing interests: The authors declare no competing interests.
References
-
- Al-Otaish H, Al-Ayadhi L, Bjørklund G, Chirumbolo S, Urbina MA, El-Ansary A (2018) Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder. Metab Brain Dis 33(3):843–854
-
- Aldred S, Moore KM, Fitzgerald M, Waring RH (2003) Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33(1):93–97
-
- Almulla AF, Thipakorn Y, Tunvirachaisakul C, Maes M (2023) The Tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis. Autism Res 16(12):2302–2315
-
- Bala KA, Doğan M, Mutluer T, Kaba S, Aslan O, Balahoroğlu R, Çokluk E, Üstyol L, Kocaman S (2016) Plasma amino acid profile in autism spectrum disorder (ASD). Eur Rev Med Pharmacol Sci 20(5):923–929
-
- Belov, Kirdajova D, Kriska J, Tureckova J, Anderova M (2020) Ischemia-Triggered glutamate excitotoxicity from the perspective of glial cells. Front Cell Neurosci 14:51
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
